Many CDMOs specialize in certain parts of the drug development lifecycle. Meanwhile, integrated turn-key offerings that support early-phase development through to commercial supply allow customers to partner with a single provider for the entire process or at any specific stage.
CDMOs, like Emergent, offering a global presence, operation across traditional and emerging therapeutic technology platforms, and GMP drug substance and GMP drug product manufacturing facilities are well-positioned to serve biopharmaceutical industry needs.
Download our white paper to learn more about the value and impact of partnering with an integrated CDMO in creating an efficient development services framework to achieve your drug substance and drug product manufacturing goals.